Universal Beteiligungs und Servicegesellschaft mbH Acquires 24,588 Shares of Cigna Group $CI

Universal Beteiligungs und Servicegesellschaft mbH boosted its holdings in shares of Cigna Group (NYSE:CI) by 9.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 276,506 shares of the health services provider’s stock after buying an additional 24,588 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Cigna Group were worth $79,703,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Brighton Jones LLC increased its stake in shares of Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after purchasing an additional 318 shares during the period. Sivia Capital Partners LLC grew its stake in shares of Cigna Group by 10.4% in the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock worth $384,000 after acquiring an additional 109 shares during the last quarter. Exchange Traded Concepts LLC raised its stake in Cigna Group by 1.5% during the 2nd quarter. Exchange Traded Concepts LLC now owns 3,468 shares of the health services provider’s stock valued at $1,146,000 after purchasing an additional 51 shares during the last quarter. Farther Finance Advisors LLC grew its position in Cigna Group by 32.6% in the 2nd quarter. Farther Finance Advisors LLC now owns 4,646 shares of the health services provider’s stock worth $1,536,000 after purchasing an additional 1,141 shares during the last quarter. Finally, Sowell Financial Services LLC increased its holdings in shares of Cigna Group by 3.7% during the 2nd quarter. Sowell Financial Services LLC now owns 5,351 shares of the health services provider’s stock worth $1,769,000 after purchasing an additional 189 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insiders Place Their Bets

In other Cigna Group news, CEO David Cordani acquired 4,134 shares of Cigna Group stock in a transaction on Monday, November 3rd. The shares were purchased at an average cost of $241.88 per share, with a total value of $999,931.92. Following the completion of the purchase, the chief executive officer owned 157,935 shares in the company, valued at $38,201,317.80. The trade was a 2.69% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.70% of the stock is owned by corporate insiders.

Cigna Group Stock Down 0.4%

Shares of NYSE CI opened at $271.12 on Wednesday. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.74. The company has a market cap of $72.42 billion, a price-to-earnings ratio of 11.96, a price-to-earnings-growth ratio of 0.96 and a beta of 0.26. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00. The firm’s 50-day simple moving average is $273.99 and its 200 day simple moving average is $286.17.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. The business had revenue of $69.57 billion during the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. Cigna Group’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same quarter last year, the business posted $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, research analysts expect that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have commented on the company. Wolfe Research reduced their price objective on Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, October 15th. Cantor Fitzgerald dropped their price objective on shares of Cigna Group from $365.00 to $325.00 in a research note on Friday, October 31st. Leerink Partners decreased their target price on shares of Cigna Group from $300.00 to $270.00 in a research report on Friday, October 31st. Robert W. Baird cut their price target on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a research note on Thursday, December 11th. Finally, Guggenheim reaffirmed a “buy” rating and set a $318.00 price objective on shares of Cigna Group in a report on Tuesday, December 2nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $330.48.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.